38 Publications (Page 1 of 2)
2020
A Randomized, Double-Blind, Placebo-Controlled, Phase II Study of Regorafenib vs. Placebo in Advanced/Metastatic, Treatment-Refractory Liposarcoma: Results from the SARC024 Study.
RF, RiedelRiedel, Richard FRF, RiedelKV, BallmanKV, BallmanBallman, Karla VAttia, StevenY, LuY, LuLoggers, Elizabeth TS, AttiaS, AttiaET, LoggersGanjoo, Kristen NET, LoggersKN, GanjooKN, GanjooLivingston, Michael BMB, LivingstonMB, LivingstonChow, WarrenWright, JenniferW, ChowW, ChowWard, John HJ, WrightJ, WrightRushing, DanielJH, WardJH, WardD, RushingD, RushingOkuno, Scott HSH, OkunoSH, OkunoReed, Damon RDR, ReedDR, ReedLiebner, David AKeedy, Vicki LDA, LiebnerDA, LiebnerRG, MakiRG, MakiMascarenhas, LeoDavis, Lara ERyan, ChristopherReinke, Denise K and Maki, Robert G
The oncologist, July 23, 2020. | Journal Article
 
Pharmacokinetics of doxorubicin following concomitant intravenous administration of olaratumab (IMC‐3G3) to patients with advanced soft tissue sarcoma
Villalobos, Victor MMo, GaryAgulnik, MarkPollack, Seth MRushing, Daniel ASingh, ArunVan Tine, Brian AMcNaughton, RhianDecker, Rodney LZhang, WeiShahir, Ashwin and Cronier, Damien M
Cancer Medicine, vol. 9, (no. 3), pp. 893, February 2020. | Journal Article
2019
Overall survival and histology‐specific subgroup analyses from a phase 3, randomized controlled study of trabectedin or dacarbazine in patients with advanced liposarcoma or leiomyosarcoma
Patel, ShreyaskumarPatel, ShreyaskumarPatel, ShreyaskumarPatel, ShreyaskumarPatel, ShreyaskumarPatel, Shreyaskumarvon Mehren, Margaretvon Mehren, MargaretReed, Damon RReed, Damon RReed, Damon RReed, Damon RReed, Damon RReed, Damon RKaiser, PamelaKaiser, PamelaKaiser, PamelaKaiser, PamelaKaiser, PamelaKaiser, PamelaCharlson, JohnCharlson, JohnCharlson, JohnCharlson, JohnCharlson, JohnCharlson, JohnRyan, Christopher WRyan, Christopher WRyan, Christopher WRyan, Christopher WRyan, Christopher WRyan, Christopher WRushing, DanielRushing, DanielRushing, DanielRushing, DanielRushing, DanielRushing, DanielLivingston, MichaelLivingston, MichaelLivingston, MichaelLivingston, MichaelLivingston, MichaelLivingston, MichaelSingh, ArunSingh, ArunSingh, ArunSingh, ArunSingh, ArunSingh, ArunSeth, RahulSeth, RahulSeth, RahulSeth, RahulSeth, RahulSeth, RahulForscher, CharlesForscher, CharlesForscher, CharlesForscher, CharlesForscher, CharlesForscher, CharlesD'Amato, GinaD'Amato, GinaD'Amato, GinaD'Amato, GinaD'Amato, GinaD'Amato, GinaChawla, Sant PChawla, Sant PChawla, Sant PChawla, Sant PChawla, Sant PChawla, Sant PMcCarthy, SharonMcCarthy, SharonMcCarthy, SharonMcCarthy, SharonMcCarthy, SharonMcCarthy, SharonWang, GeorgeWang, GeorgeWang, GeorgeWang, GeorgeWang, GeorgeWang, GeorgeParekh, TrilokParekh, TrilokParekh, TrilokParekh, TrilokParekh, TrilokParekh, TrilokKnoblauch, RolandKnoblauch, RolandKnoblauch, RolandKnoblauch, RolandKnoblauch, RolandKnoblauch, RolandHensley, Martee LHensley, Martee LHensley, Martee LHensley, Martee LHensley, Martee LHensley, Martee LMaki, Robert GMaki, Robert GMaki, Robert GMaki, Robert GMaki, Robert GMaki, Robert GDemetri, George DDemetri, George DDemetri, George DDemetri, George DDemetri, George D and Demetri, George D
Cancer, vol. 125, (no. 15), pp. 2620, August 1, 2019. | Journal Article
 
Randomized Double-Blind Phase II Study of Regorafenib in Patients With Metastatic Osteosarcoma
Davis, Lara EDavis, Lara EBolejack, VanessaBolejack, VanessaRyan, Christopher WRyan, Christopher WGanjoo, Kristen NGanjoo, Kristen NLoggers, Elizabeth TLoggers, Elizabeth TChawla, SantChawla, SantAgulnik, MarkAgulnik, MarkLivingston, Michael BLivingston, Michael BReed, DamonReed, DamonKeedy, VickyKeedy, VickyRushing, DanielRushing, DanielOkuno, ScottOkuno, ScottReinke, Denise KReinke, Denise KRiedel, Richard FRiedel, Richard FAttia, StevenAttia, StevenMascarenhas, LeoMascarenhas, LeoMaki, Robert G and Maki, Robert G
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 37, (no. 16), pp. 1431, 2019-06-01. | Journal Article
2018
A randomized, double-blind, placebo-controlled, phase II study of regorafenib vs placebo in advanced/metastatic, treatment-refractory liposarcoma: results from the SARC024 study
Riedel, Richard FRiedel, Richard FBallman, Karla VBallman, Karla VLu, YaoLu, YaoAttia, StevenAttia, StevenLoggers, Elizabeth TriceLoggers, Elizabeth TriceGanjoo, Kristen NGanjoo, Kristen NLivingston, Michael BLivingston, Michael BChow, Warren AllenChow, Warren AllenWright, Jennifer AWright, Jennifer AWard, John HarrisWard, John HarrisRushing, Daniel ARushing, Daniel AOkuno, Scott HOkuno, Scott HReed, Damon RReed, Damon RLiebner, David ALiebner, David AKeedy, Vicki LeighKeedy, Vicki LeighMascarenhas, LeoMascarenhas, LeoDavis, Lara EmilyDavis, Lara EmilyRyan, Christopher WRyan, Christopher WReinke, Denise KReinke, Denise KMaki, Robert G and Maki, Robert G
Journal of Clinical Oncology, vol. 36, (no. 15_suppl), pp. 11505, 2018-05-20. | Journal Article
 
Association of Dasatinib With Progression-Free Survival Among Patients With Advanced Gastrointestinal Stromal Tumors Resistant to Imatinib
Schuetze, Scott MSchuetze, Scott MSchuetze, Scott MBolejack, VanessaBolejack, VanessaBolejack, VanessaThomas, Dafydd GThomas, Dafydd GThomas, Dafydd Gvon Mehren, Margaretvon Mehren, Margaretvon Mehren, MargaretPatel, ShreyaskumarPatel, ShreyaskumarPatel, ShreyaskumarSamuels, BrianSamuels, BrianSamuels, BrianChoy, EdwinChoy, EdwinChoy, EdwinD'Amato, GinaD’Amato, GinaD’Amato, GinaStaddon, Arthur PStaddon, Arthur PStaddon, Arthur PGanjoo, Kristen NGanjoo, Kristen NGanjoo, Kristen NChow, Warren AChow, Warren AChow, Warren ARushing, Daniel ARushing, Daniel ARushing, Daniel AForscher, Charles AForscher, Charles AForscher, Charles APriebat, Dennis APriebat, Dennis APriebat, Dennis ALoeb, David MLoeb, David MLoeb, David MChugh, RashmiChugh, RashmiChugh, RashmiOkuno, ScottOkuno, ScottOkuno, ScottReinke, Denise KReinke, Denise KReinke, Denise KBaker, Laurence HBaker, Laurence H and Baker, Laurence H
JAMA Oncology, vol. 4, (no. 6), pp. 820, 2018-06-01. | Journal Article
2017
A phase II trial of regorafenib (REGO) in patients (pts) with advanced Ewing sarcoma and related tumors (EWS) of soft tissue and bone: SARC024 trial results
Attia, StevenBolejack, VanessaGanjoo, Kristen NGeorge, SuzanneAgulnik, MarkRushing, Daniel ALoggers, Elizabeth TriceLivingston, Michael BWright, Jennifer AChawla, Sant POkuno, Scott HReinke, Denise KRiedel, Richard FDavis, Lara EmilyRyan, Christopher W and Maki, Robert G
Journal of Clinical Oncology, vol. 35, (no. 15_suppl), pp. 11005, 2017-05-20. | Journal Article
 
Efficacy and safety of trabectedin or dacarbazine in patients with advanced uterine leiomyosarcoma after failure of anthracycline-based chemotherapy: Subgroup analysis of a phase 3, randomized clinical trial
Hensley, Martee LHensley, Martee LHensley, Martee LPatel, Shreyaskumar RPatel, Shreyaskumar RPatel, Shreyaskumar Rvon Mehren, Margaretvon Mehren, Margaretvon Mehren, MargaretGanjoo, KristenGanjoo, KristenGanjoo, KristenJones, Robin LJones, Robin LJones, Robin LStaddon, ArthurStaddon, ArthurStaddon, ArthurRushing, DanielRushing, DanielRushing, DanielMilhem, MohammedMilhem, MohammedMilhem, MohammedMonk, BradleyMonk, BradleyMonk, BradleyWang, GeorgeWang, GeorgeWang, GeorgeMcCarthy, SharonMcCarthy, SharonMcCarthy, SharonKnoblauch, Roland EKnoblauch, Roland EKnoblauch, Roland EParekh, Trilok VParekh, Trilok VParekh, Trilok VMaki, Robert GMaki, Robert GMaki, Robert GDemetri, George DDemetri, George D and Demetri, George D
Gynecologic Oncology, vol. 146, (no. 3), pp. 537, September 2017. | Journal Article
 
SARC006: Phase II Trial of Chemotherapy in Sporadic and Neurofibromatosis Type 1 Associated Chemotherapy-Naive Malignant Peripheral Nerve Sheath Tumors
Higham, ChristineHigham, Christine SHigham, Christine SHigham, Christine SHigham, Christine SHigham, ChristineSteinberg, Seth MSteinberg, SethSteinberg, SethSteinberg, Seth MSteinberg, Seth MSteinberg, Seth MDombi, EvaDombi, EvaDombi, EvaDombi, EvaDombi, EvaDombi, EvaPerry, AriePerry, AriePerry, AriePerry, AriePerry, AriePerry, ArieHelman, LeeHelman, Lee JHelman, LeeHelman, Lee JHelman, Lee JHelman, Lee JSchuetze, Scott MSchuetze, ScottSchuetze, Scott MSchuetze, ScottSchuetze, Scott MSchuetze, Scott MLudwig, Joseph ALudwig, Joseph ALudwig, Joseph ALudwig, JosephLudwig, JosephLudwig, Joseph AStaddon, ArthurStaddon, ArthurStaddon, ArthurStaddon, ArthurStaddon, ArthurStaddon, ArthurMilhem, MohammedMilhem, Mohammed MMilhem, Mohammed MMilhem, MohammedMilhem, Mohammed MMilhem, Mohammed MRushing, DanielRushing, DanielRushing, DanielRushing, DanielRushing, DanielRushing, DanielJones, Robin LJones, RobinJones, RobinJones, Robin LJones, Robin LJones, Robin LLivingston, MichaelLivingston, MichaelLivingston, MichaelLivingston, MichaelLivingston, MichaelLivingston, MichaelGoldman, StewartGoldman, StewartGoldman, StewartGoldman, StewartGoldman, StewartGoldman, StewartMoertel, ChristopherMoertel, ChristopherMoertel, ChristopherMoertel, ChristopherMoertel, ChristopherMoertel, ChristopherWagner, LarsWagner, LarsWagner, LarsWagner, LarsWagner, LarsWagner, LarsJanhofer, DavidJanhofer, DavidJanhofer, DavidJanhofer, DavidJanhofer, DavidJanhofer, DavidAnnunziata, Christina MAnnunziata, Christina MAnnunziata, ChristinaAnnunziata, ChristinaAnnunziata, Christina MAnnunziata, Christina MReinke, DeniseReinke, DeniseReinke, DeniseReinke, DeniseReinke, DeniseReinke, DeniseLong, LaurenLong, LaurenLong, LaurenLong, LaurenLong, LaurenLong, LaurenViskochil, DavidViskochil, DavidViskochil, DavidViskochil, DavidViskochil, DavidViskochil, DavidBaker, LarryBaker, LarryBaker, LarryBaker, LarryBaker, LarryBaker, LarryWidemann, BrigitteWidemann, Brigitte CWidemann, Brigitte CWidemann, Brigitte CWidemann, Brigitte and Widemann, Brigitte C
Sarcoma, vol. 2017, pp. 8, 20170912. | Journal Article
2016
Abstract 2258: Digital whole slide quantitative image analysis of TOPO II and P53 in sarcomas evaluating both primary and lung metastatic tumors
Strack, MargaretStrack, MargaretSandusky, GeorgeSandusky, GeorgeRushing, Daniel and Rushing, Daniel
Cancer Research, vol. 76, (no. 14 Supplement), pp. 2258, 2016-07-15. | Journal Article
 
Abstract CT145: A phase I open-label study to evaluate the effect of olaratumab on the pharmacokinetics (PK) of doxorubicin (Dox) in patients with advanced soft tissue sarcoma (STS)
Villalobos, VictorAgulnik, MarkPollack, Seth MRushing, Daniel ASingh, ArunVan Tine, Brian AOkereke, ChukwuemekaNg, Wee Teck and Cronier, Damien M
Cancer Research, vol. 76, (no. 14 Supplement), pp. CT145, 2016-07-15. | Journal Article
 
Clinical benefit of a precision medicine based approach for guiding treatment of refractory cancers.
Radovich, MilanRadovich, MilanRadovich, MilanRadovich, MilanRadovich, MilanKiel, Patrick JKiel, Patrick JKiel, Patrick JKiel, Patrick JKiel, Patrick JNance, Stacy MNance, Stacy MNance, Stacy MNance, Stacy MNance, Stacy MNiland, Erin ENiland, Erin ENiland, Erin ENiland, Erin ENiland, Erin EParsley, Megan EParsley, Megan EParsley, Megan EParsley, Megan EParsley, Megan EFerguson, Meagan EFerguson, Meagan EFerguson, Meagan EFerguson, Meagan EFerguson, Meagan EJiang, GuanglongJiang, GuanglongJiang, GuanglongJiang, GuanglongJiang, GuanglongAmmakkanavar, Natraj RAmmakkanavar, Natraj RAmmakkanavar, Natraj RAmmakkanavar, Natraj RAmmakkanavar, Natraj REinhorn, Lawrence HEinhorn, Lawrence HEinhorn, Lawrence HEinhorn, Lawrence HEinhorn, Lawrence HCheng, LiangCheng, LiangCheng, LiangCheng, LiangCheng, LiangNassiri, MehdiNassiri, MehdiNassiri, MehdiNassiri, MehdiNassiri, MehdiDavidson, Darrell DDavidson, Darrell DDavidson, Darrell DDavidson, Darrell DDavidson, Darrell DRushing, Daniel ARushing, Daniel ARushing, Daniel ARushing, Daniel ARushing, Daniel ALoehrer, Patrick JLoehrer, Patrick JLoehrer, Patrick JLoehrer, Patrick JLoehrer, Patrick JPili, RobertoPili, RobertoPili, RobertoPili, RobertoPili, RobertoHanna, NasserHanna, NasserHanna, NasserHanna, NasserHanna, NasserCallaghan, J ThomasCallaghan, J ThomasCallaghan, J ThomasCallaghan, J ThomasCallaghan, J ThomasSkaar, Todd CSkaar, Todd CSkaar, Todd CSkaar, Todd CSkaar, Todd CHelft, Paul RHelft, Paul RHelft, Paul RHelft, Paul RHelft, Paul RShahda, SafiShahda, SafiShahda, SafiShahda, SafiShahda, SafiO'Neil, Bert HO'Neil, Bert HO'Neil, Bert HO'Neil, Bert HO'Neil, Bert HSchneider, Bryan PSchneider, Bryan PSchneider, Bryan PSchneider, Bryan P and Schneider, Bryan P
Oncotarget, July 15, 2016. | Journal Article
 
Phase 2 study of dasatinib in patients with alveolar soft part sarcoma, chondrosarcoma, chordoma, epithelioid sarcoma, or solitary fibrous tumor.
Schuetze, Scott MSchuetze, Scott MSchuetze, Scott MBolejack, VanessaBolejack, VanessaBolejack, VanessaChoy, EdwinChoy, EdwinChoy, EdwinGanjoo, Kristen NGanjoo, Kristen NGanjoo, Kristen NStaddon, Arthur PStaddon, Arthur PStaddon, Arthur PChow, Warren AChow, Warren AChow, Warren ATawbi, Hussein ATawbi, Hussein ATawbi, Hussein ASamuels, Brian LSamuels, Brian LSamuels, Brian LPatel, Shreyaskumar RPatel, Shreyaskumar RPatel, Shreyaskumar RMehren, Margaretvon Mehren, MargaretMehren, MargaretD'Amato, GinaD'Amato, GinaD'Amato, GinaLeu, Kirsten MLeu, Kirsten MLeu, Kirsten MLoeb, David MLoeb, David MLoeb, David MForscher, Charles AForscher, Charles AForscher, Charles AMilhem, Mohammed MMilhem, Mohammed MMilhem, Mohammed MRushing, Daniel ARushing, Daniel ARushing, Daniel ALucas, David RLucas, David RLucas, David RChugh, RashmiChugh, RashmiChugh, RashmiReinke, Denise KReinke, Denise KReinke, Denise KBaker, Laurence HBaker, Laurence H and Baker, Laurence H
Cancer, October 3, 2016. | Journal Article
 
Phase 2 study of dasatinib in patients with previously treated, high-grade, advanced sarcoma
Schuetze, ScottSchuetze, ScottSchuetze, ScottSchuetze, ScottWathen, J.Wathen, J.Wathen, J.Wathen, J.Lucas, DavidLucas, DavidLucas, DavidLucas, DavidChoy, EdwinChoy, EdwinChoy, EdwinChoy, EdwinSamuels, BrianSamuels, BrianSamuels, BrianSamuels, BrianStaddon, ArthurStaddon, ArthurStaddon, ArthurStaddon, ArthurGanjoo, KristenGanjoo, KristenGanjoo, KristenGanjoo, KristenMehren, MargaretMehren, MargaretMehren, MargaretMehren, MargaretChow, WarrenChow, WarrenChow, WarrenChow, WarrenLoeb, DavidLoeb, DavidLoeb, DavidLoeb, DavidTawbi, HusseinTawbi, HusseinTawbi, HusseinTawbi, HusseinRushing, DanielRushing, DanielRushing, DanielRushing, DanielPatel, ShreyaskumarPatel, ShreyaskumarPatel, ShreyaskumarPatel, ShreyaskumarThomas, DafyddThomas, DafyddThomas, DafyddThomas, DafyddChugh, RashmiChugh, RashmiChugh, RashmiChugh, RashmiReinke, DeniseReinke, DeniseReinke, DeniseReinke, DeniseBaker, LaurenceBaker, LaurenceBaker, Laurence and Baker, Laurence
Cancer, vol. 122, (no. 6), pp. 868, 20160315. | Journal Article
 
SARC009: Phase 2 study of dasatinib in patients with previously treated, high‐grade, advanced sarcoma
Schuetze, Scott MSchuetze, Scott MSchuetze, Scott MSchuetze, Scott MWathen, J. KyleWathen, J. KyleWathen, J. KyleWathen, J. KyleLucas, David RLucas, David RLucas, David RLucas, David RChoy, EdwinChoy, EdwinChoy, EdwinChoy, EdwinSamuels, Brian LSamuels, Brian LSamuels, Brian LSamuels, Brian LStaddon, Arthur PStaddon, Arthur PStaddon, Arthur PStaddon, Arthur PGanjoo, Kristen NGanjoo, Kristen NGanjoo, Kristen NGanjoo, Kristen Nvon Mehren, Margaretvon Mehren, Margaretvon Mehren, Margaretvon Mehren, MargaretChow, Warren AChow, Warren AChow, Warren AChow, Warren ALoeb, David MLoeb, David MLoeb, David MLoeb, David MTawbi, Hussein ATawbi, Hussein ATawbi, Hussein ATawbi, Hussein ARushing, Daniel ARushing, Daniel ARushing, Daniel ARushing, Daniel APatel, Shreyaskumar RPatel, Shreyaskumar RPatel, Shreyaskumar RPatel, Shreyaskumar RThomas, Dafydd GThomas, Dafydd GThomas, Dafydd GThomas, Dafydd GChugh, RashmiChugh, RashmiChugh, RashmiChugh, RashmiReinke, Denise KReinke, Denise KReinke, Denise KReinke, Denise KBaker, Laurence HBaker, Laurence HBaker, Laurence H and Baker, Laurence H
Cancer, vol. 122, (no. 6), pp. 874, March 15, 2016. | Journal Article
2013
Results of an international randomized phase III trial of the mammalian target of rapamycin inhibitor ridaforolimus versus placebo to control metastatic sarcomas in patients after benefit from prior chemotherapy.
Demetri, George DChawla, Sant PRay-Coquard, IsabelleCesne, AxelLe Cesne, AxelStaddon, Arthur PMilhem, Mohammed MPenel, NicolasRiedel, RichardBui-Nguyen, BinhCranmer, LeeReichardt, PeterBompas, EmmanuelleAlcindor, ThierryRushing, DanielSong, YangLee, Ruey-MinEbbinghaus, ScotEid, Joseph ELoewy, John WHaluska, Frank GDodion, Pierre F and Blay, Jean-Yves
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 31, (no. 19), pp. 2485-92, 2013/Jul/1. | Journal Article
 
SARC006: Phase II trial of chemotherapy in sporadic and neurofibromatosis type 1 (NF1)-associated high-grade malignant peripheral nerve sheath tumors (MPNSTs)
Widemann, Brigitte CReinke, Denise KHelman, Lee JLudwig, Joseph ASchuetze, ScottStaddon, Arthur PMilhem, Mohammed MRushing, Daniel AMoertel, Christopher LGoldman, StewartLivingston, Michael BWagner, Lars MRodler, Eve TDombi, EvaPerry, ArieAnnunziata, Christina MLong, LaurenViskochil, DavidSteinberg, Seth M and Baker, Laurence H
Journal of Clinical Oncology, vol. 31, (no. 15_suppl), pp. 10522, 2013-05-20. | Journal Article
2012
Phase III, placebo-controlled trial (SUCCEED) evaluating ridaforolimus as maintenance therapy in advanced sarcoma patients following clinical benefit from prior standard cytotoxic chemotherapy: Long-term (≥ 24 months) overall survival results
Blay, Jean-YvesChawla, Sant PRay-Coquard, IsabelleCesne, Axel LeStaddon, Arthur PMilhem, Mohammed MPenel, NicolasRiedel, Richard FBui Nguyen, BinhCranmer, Lee DReichardt, PeterBompas, EmmanuelleAlcindor, ThierryRushing, Daniel ASong, YangEbbinghaus, ScotHaluska, Frank GDodion, Pierre F and Demetri, George D
Journal of Clinical Oncology, vol. 30, (no. 15_suppl), pp. 10010, 2012-05-20. | Journal Article
 
Substitution of cisplatin for etoposide in 2 of 3 induction cycles of CAV/IE with subsequent irinotecan and vincristine for relapse in adults with Ewing sarcoma (ES) and primitive neuroectodermal tumor (PNET)
Rushing, Daniel AEzewuiro, ObiageliStaehler, Sandra SPotter, KristinRojas, Luis and Wagner, Stephanie Glacy
Journal of Clinical Oncology, vol. 30, (no. 15_suppl), pp. 9571, 2012-05-20. | Journal Article
2011
A phase I study of the safety and pharmacokinetics of the hypoxia-activated prodrug TH-302 in combination with doxorubicin in patients with advanced soft tissue sarcoma.
Ganjoo, KristenCranmer, LeeButrynski, James ERushing, DanielAdkins, Douglas ROkuno, Scott HLorente, GustavoKroll, StewLangmuir, Virginia K and Chawla, Sant P
Oncology, vol. 80, (no. 1-2), pp. 50-6, 2011. | Journal Article
2007
Topiramate in the Treatment of Neuropathic Pain in Patients with Cancer
Bendaly, Edmond AJordan, Carol AStaehler, Sandra S and Rushing, Daniel A
Supportive Cancer Therapy, vol. 4, (no. 4), pp. 246, September 2007. | Journal Article
2006
Gastrointestinal stromal tumors: CT and MRI findings
Sandrasegaran, K.Rajesh, A.Rushing, D.A.Rydberg, J.Akisik, F.M. and Henley, J.D.
Clinical Imaging, vol. 30, (no. 1), 2006. | Journal Article
 
Phase II study of intravenous TZT‐1027 in patients with advanced or metastatic soft‐tissue sarcomas with prior exposure to anthracycline‐based chemotherapy
Patel, ShreyaskumarPatel, ShreyaskumarKeohan, Mary LouiseKeohan, Mary LouiseSaif, M. WasifSaif, M. WasifRushing, DanielRushing, DanielBaez, LuisBaez, LuisFeit, KevieFeit, KevieDeJager, RobertDeJager, RobertAnderson, Sibyl and Anderson, Sibyl
Cancer, vol. 107, (no. 12), pp. 2887, 15 December 2006. | Journal Article
2005
Gastrointestinal stromal tumors: clinical, radiologic, and pathologic features.
Sandrasegaran, KumaresanSandrasegaran, KumaresanRajesh, ArumugamRajesh, ArumugamRydberg, JonasRydberg, JonasRushing, Daniel ARushing, Daniel AAkisik, Fatih MAkisik, Fatih MHenley, John D and Henley, John D
AJR. American journal of roentgenology, vol. 184, (no. 3), pp. 803-11, 2005/Mar. | Journal Article
 
Gastrointestinal stromal tumors: CT and MRI findings.
Sandrasegaran, KumaresanSandrasegaran, KumaresanRajesh, ArumugamRajesh, ArumugamRushing, DanielRushing, Daniel ARydberg, JonasRydberg, JonasAkisik, Fatih MAkisik, FatihHenley, John and Henley, John D
European radiology, vol. 15, (no. 7), pp. 1407-14, 2005/Jul. | Journal Article